Back
Protagonist Therapeutics Vs. Broadcom Industry Stock Comparison
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
31.42
Seasonality Move:
-0.18%
Sell
37
AVGO
Broadcom
Last Price:
1,582.98
Seasonality Move:
3.96%
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.71. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Broadcom (AVGO)
is a Sell
Is Broadcom a Buy, Sell or Hold?
- The current Broadcom [AVGO] share price is $1,580.90. The Score for AVGO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- AVGO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.71
The current trend is moderately bearish and PTGX is experiencing slight selling pressure.
AVGO Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 51.21 | Buy |
| Chaikin Money Flow: | -137490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.68 - 33.74) | Sell |
| Bollinger Bands (100): | (26.43 - 31.41) | Buy |
AVGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 82.92 | Buy |
| Relative Strength Index (14 RSI): | 55.25 | Buy |
| Chaikin Money Flow: | -939815 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1342.05 - 1648.89) | Buy |
| Bollinger Bands (100): | (1228.31 - 1473.27) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.52 | Sell |
| 20-day SMA: | 31.85 | Sell |
| 50-day SMA: | 29.34 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 32.27 | Sell |
| 20-day EMA: | 31.89 | Sell |
| 50-day EMA: | 30.33 | Buy |
| 200-day EMA: | 25.81 | Buy |
AVGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1701.33 | Sell |
| 20-day SMA: | 1519.01 | Buy |
| 50-day SMA: | 1401.52 | Buy |
| 200-day SMA: | 1160.84 | Buy |
| 8-day EMA: | 1634.07 | Sell |
| 20-day EMA: | 1556.8 | Buy |
| 50-day EMA: | 1447.56 | Buy |
| 200-day EMA: | 1201.91 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Broadcom Earnings Growth & AVGO Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.68 per share, an increase next quarter of $3.12 per share, an increase this year of $5.71 per share, and an increase next year of $12.21 per share.
Protagonist Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Broadcom Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||